Vacinas
Estudo com mais de 5,1 milhões de indivíduos vacinados mostrou que a incidência de miocardite após receberem a vacina da Pfizer foi baixa e mais comum após a segunda dose em homens jovens.
8 Out, 2021 | 12:00hMyocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel – New England Journal of Medicine
Comentário: Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines – TCTMD
Estudo relacionado: Myocarditis after Covid-19 Vaccination in a Large Health Care Organization – New England Journal of Medicine
Comentários no Twitter
In an Israeli Ministry of Health database, 136 cases of myocarditis were detected among 5 million vaccinated persons. #Covid19vaccine #IDTwitter https://t.co/c1wLBCq8UN pic.twitter.com/D2DAGrIuXe
— NEJM (@NEJM) October 6, 2021
Two new @NEJM reports on Pfizer vaccine related myocarditis: very rare (~2 per 100,000) and usually mild; in-depth review of 190 cases, most cases were in males 16-29 years, 2nd dosehttps://t.co/nHgxXTgQ6ohttps://t.co/pchL0VDi4b pic.twitter.com/7pUxNy36Zo
— Eric Topol (@EricTopol) October 6, 2021
Perspectiva | Ninguém está seguro até que todos estejam.
8 Out, 2021 | 11:59hNo one is safe until we are all safe – Science Translational Medicine
Comentário: Covid ‘still running rampant’ worldwide, warns creator of Oxford vaccine – The Guardian
Conteúdo relacionado: Opinion: Vaccine Nationalism Harms Everyone and Protects No One
Comentário no Twitter
No one is safe until we all are safe, by Sarah Gilbert @JennerInstitute @NDMOxford @UniofOxford and @DrRHatchett @CEPIVaccines
With a forecast of global vaccine supply for 2021https://t.co/iUgC6euvz6 @ScienceTM a large proportion are Sinopharm and Sinovac from China pic.twitter.com/w4KfUAsU45— Eric Topol (@EricTopol) October 6, 2021
Suécia e Dinamarca pausam o uso da vacina da Moderna contra COVID-19 em grupos jovens.
8 Out, 2021 | 11:57hSweden, Denmark pause Moderna COVID-19 vaccine for younger age groups – Reuters
OMS aprova a primeira vacina contra malária para crianças em risco.
8 Out, 2021 | 11:56hWHO recommends groundbreaking malaria vaccine for children at risk – World Health Organization
Comentários:
WHO Approves First Ever Malaria Vaccine – Health Policy Watch
In major decision, WHO recommends broad rollout of world’s first malaria vaccine – STAT
Why the WHO approval of the first malaria vaccine is a big deal – Vox
WHO greenlights the world’s first malaria vaccine — but it’s not a perfect shot – NPR
The World Health Organization Just Endorsed The World’s First Malaria Vaccine – TIME
WHO Backs Widespread Use Of First Malaria Vaccine – Forbes
World’s 1st malaria vaccine recommended by WHO – LiveScience
Comentários no Twitter
I started my career as a #malaria researcher, and I longed for the day that we would have an effective vaccine against this ancient and terrible disease. Today is that day: @WHO is recommending the broad use of the world’s first malaria vaccine. #EndMalaria https://t.co/Oh1O155tYj
— Tedros Adhanom Ghebreyesus (@DrTedros) October 6, 2021
(fio – clique para saber mais)
A child dies from #malaria every two minutes.
One death is one too many.🚨 Today, WHO recommends RTS,S, a groundbreaking malaria vaccine, to reduce child illness & deaths in areas with moderate and high malaria transmission https://t.co/xSk58nTIV1#VaccinesWork pic.twitter.com/mSECLtRhQs
— World Health Organization (WHO) (@WHO) October 6, 2021
Recomendações da EMA sobre doses extras e de reforço das vacinas mRNA da BioNTech/Pfizer e da Moderna.
8 Out, 2021 | 11:26hComirnaty and Spikevax: EMA recommendations on extra doses and boosters – European Medicines Agency
Conteúdo relacionado: The difference between COVID-19 ‘third doses’ and ‘boosters’ – Emory News Center
Comentário no Twitter
EMA recommended additional doses and boosters for #Comirnaty and #Spikevax. https://t.co/qefPg2kMMO
In this context, see below what the difference between an additional dose and a #boosterdose is. pic.twitter.com/HeyOACbWXm
— EU Medicines Agency (@EMA_News) October 5, 2021
Suplemento | Triunfos da vacinação.
8 Out, 2021 | 11:05hPágina principal: Triumphs of Vaccination – The Journal of Infectious Diseases
Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease
The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease
Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe
Rubella Eradication: Not Yet Accomplished, but Entirely Feasible
Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication
Influenza Vaccines: Successes and Continuing Challenges
Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination
Overview of the United States’ Immunization Program
The World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade
Estudo de coorte | Efetividade da vacina da Pfizer contra qualquer infecção caiu de 88% no 1º mês após a vacinação completa para 47% após 5 meses. A efetividade da vacina contra internações permaneceu alta: 87% em 1 mês e 88% depois de 5 meses da vacinação completa, sem declínio significativo.
5 Out, 2021 | 11:36hComentário: Expert reaction to study on Pfizer-BioNTech vaccine effectiveness up to 6 months – Science Media Centre
Comentário no Twitter
Study of 3.4 million people @aboutKP @TheLancet
Vaccine efficacy against infections:
– First month post: 88%
– 5 months post: 47%But vaccine efficacy against hospitalization (Figure):
– First month post: 87%
– 5 months post: 88 %https://t.co/1Gse0FKpoI pic.twitter.com/p9wyiaWGeg— Vincent Rajkumar (@VincentRK) October 4, 2021
Estudo de coorte | Miocardite aguda após vacina de mRNA contra COVID-19 em maiores de 18 anos é rara, e a maioria dos casos não é grave.
5 Out, 2021 | 11:34hEditorial: COVID-19 Messenger RNA Vaccination and Myocarditis—A Rare and Mostly Mild Adverse Effect
Comentário no Twitter
New report on very rare acute myocarditis after mRNA vaccination in age 18+
5.8 cases/million after 2nd dose, 0.8/million 1st dose, all cases fully resolved with conservative managementhttps://t.co/Mfh5ImiSpW @KPSCALnews @KPSCalResearch @JAMAInternalMed— Eric Topol (@EricTopol) October 4, 2021
Editorial | Ética clínica: consentimento para vacinação de crianças.
4 Out, 2021 | 10:32hClinical ethics: consent for vaccination in children – Archives of Disease in Childhood
Nova análise mostra que os benefícios de se aplicar 2 doses de vacina contra COVID-19 em crianças de 12 a 17 anos supera os riscos.
4 Out, 2021 | 10:30hComunicado de imprensa: New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly outweigh risks – The Royal Society of Medicine
Relatório original: Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis
Contéudo relacionado: Covid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors.